The medical and health care industry in China, which started in 1980s, has rapidly developed into a unique industry in just over ten years. The main reason for health care industry's vigorous development is the remarkable improvement of people's living standards; Secondly, the change of people's lifestyle is an important opportunity for the development of health care industry; Multi-level social life demands provide a broad space for the development of health care industry. In 2006, the scale of health care products enterprises in China was basically a pyramid structure, that is, enterprises with investment scale above 65.438+0.45%, enterprises with investment scale between 50 million yuan and 65.438+0.2%, and enterprises with investment scale of 65.438+0.6%. In 2006, China's total import and export of medicines and health products exceeded $30 billion, reaching $30.67 billion, a year-on-year increase of 20.4%. Among them, the export value 196 1 billion dollars, up 26.3% year-on-year; Import value 1 106 billion USD, up1/0.2% year-on-year.
In 2007, China's foreign trade in medical and health products reached a record high, reaching US$ 38.59 billion, up 25.6% year-on-year, of which US$ 24.59 billion was exported, up 25. 1% year-on-year, which was equivalent to the overall export growth rate of China. Imports reached US$ 654.38+04 billion, up 26.6% year-on-year. The annual foreign trade surplus of medicine reached $65.438+0.059 billion, but the growth rate of imports was 654.38+0.5 percentage points higher than that of exports.
From June, 5438 to September, 2008, the total import and export of health care products in China was 654.38+55 billion US dollars, up 29.28% year-on-year, of which the total export was 62.67 million US dollars, up 2654.38+0.32% year-on-year; The import value was $823 1 10,000, up 36.08% year-on-year. From the end of 1980s to the beginning of 1990s, it was the first period of rapid development of health food industry. From 1995 to 1998, the health food industry experienced a trough, with the number of enterprises and sales shrinking in a large area. After 1996, the state has successively promulgated a series of regulations on the health food industry. Due to the gradual standardization of the industry and the rise of a new round of health food consumption boom, the health food industry has entered an unprecedented period of rapid development since 1998.
In 2000, China began to abolish health care drugs and rectify the health food industry. In 200 1 and 2002, the health food industry began to decline sharply. With the improvement of China's overall economic situation, new health foods that adapt to the new health concept are constantly emerging. Market rectification has enhanced consumers' confidence in buying and made the industry show vitality again. By 2004, the output value of health food in China reached nearly 50 billion yuan. Since 2005, the health food industry in China has entered a new growth period. The promotion of enterprises and the consumption behavior of consumers tend to be rational, and consumers pay more attention to quality, brand and practical effect when choosing products. 2009-20 12 China Health Care Industry Survey and Strategic Consulting Report
At present, only 22 kinds of health products are allowed to be produced in China, which can regulate immunity, blood lipid, blood sugar, anti-aging and improve gastrointestinal function. In recent years, obesity, non-insulin-dependent diabetes, hypertension, coronary heart disease and other chronic diseases have increased year by year due to overeating and excessive fat intake. Therefore, functional nutritious food which is beneficial to prevent and improve these diseases has been welcomed by middle-aged and elderly consumers. With the arrival of "aging society", the demand for health care products by "silver-haired people" is very strong, and their purchasing power is also very strong. Coupled with the middle-aged people under the dual pressure of family and career, this is a huge consumer market. Another kind of health care products that can not be ignored is nutritional supplements such as vitamins and minerals. According to statistics, among the 65.438+76 billion students in 850,000 primary and secondary schools in China, the intake of protein, calcium, zinc, vitamin A and vitamin B2 is generally insufficient, and the proportion of iron deficiency anemia is as high as 30% to 40%. Parents of infants and young children also invest in nutrition and health products. In recent years, beauty and health care products have greatly surpassed and become a new growth point to stimulate the growth of health care products. According to market surveys in Beijing and Shanghai, at present, 93% of children, 78% of the elderly and nearly 50% of young and middle-aged people consume health food, and more than 95% of families always have different types of nutritious health food. It can be seen that the number of people who establish the concept of health investment is increasing, and the number of people who buy health care products is also expanding. From the perspective of industry development, at present, the per capita drug consumption in China is only 1/30 to 1/40 of the developed countries in Europe and America, and the per capita consumption expenditure of health care products is only 1/20 of the United States and1/5 of Japan, which also shows the huge growth space and development potential of the medical health care products market. At the same time, China's economic development and residents' income level have maintained a high-speed growth of more than 9% in the past five years, and it is expected to continue to grow at a rate of more than 6% in the next decade. There is a strong correlation between the consumption level of medical care products and the per capita disposable income. According to the development trend of GDP and disposable income, it can be predicted that health care products will continue to grow in the next decade, reaching 2 to 3 times the current level. In addition, urban and rural residents pay more and more attention to medical care, resulting in a gradual increase in medical expenditure. The total medical expenditure of urban residents in China has exceeded150 billion yuan, with an average annual growth rate of 30%, and the total medical expenditure of rural areas has exceeded 70 billion yuan, accounting for 13 of the total expenditure, with an average annual growth rate of 14%.
However, with the intensification of competition and the change of external environment, the current health care products marketing has ushered in the era of integrated marketing. Advertising, conferences, public relations, promotion ... all kinds of means have become the necessary means of health care products marketing. Under the current circumstances, it is difficult to rise rapidly simply by relying on advertising and meeting. Integrated marketing is both the result and the need of competition. Facing the increasingly fierce market competition, the innovation of marketing model depends on the progress of science and technology, which promotes the innovation and development of marketing model. The core of health care products management is concept, the key is marketing, and the foundation is the efficacy with scientific and technological content. At the same time, we should persistently build corporate culture and build core competitiveness. Corporate culture essentially reflects the quality, ideas and courage of entrepreneurs, and is an aspect of the embodiment and reflection of the comprehensive quality and core competitiveness of enterprises. The expansion, radiation and infiltration of a good corporate culture have produced great vitality, played a great role in promoting and standardizing the development of enterprises, formed the cohesion and centripetal force of enterprises, and become the source of power for the sustained and healthy development of enterprises. In order to develop by leaps and bounds, health care products enterprises must strengthen the construction of corporate culture. Facing the fierce market environment, we need to mold our own entrepreneurial spirit, establish advanced business philosophy, create our own unique corporate culture and build our core competitiveness. Only by shaping and cultivating health care industry's century-old brand can enterprises be in an invincible position.
This research report is mainly based on the basic information published and provided by the National Bureau of Statistics, the Ministry of Commerce, the General Administration of Customs, the Ministry of Health, the State Food and Drug Administration of the United States, china association of pharmaceutical commerce, China Health Care Industry Association, SFDA Southern Institute of Pharmaceutical Economics, china association of pharmaceutical commerce, National Business Information Center, and National Economic Climate Monitoring Center, as well as a large number of domestic and foreign related publications and health care industry research units. Based on the in-depth market survey data and the overall development trend of the global health care industry, this paper analyzes and forecasts the development trend, economic operation data, main market segments, import and export, marketing and competition pattern of the health care industry in China, and probes into and judges the overall environment and development trend of the health care industry in the future. Finally, on the basis of a lot of analysis and prediction, the future development and investment strategy of the health care industry are studied. It provides accurate market intelligence information and scientific decision-making basis for enterprises such as health care product production, trade and circulation to gain insight into the opportunities in fierce market competition and adjust their business strategies in time according to market demand. It also provides accurate market intelligence information and scientific decision-making basis for strategic investors to choose suitable investment opportunities and enterprise leaders to carry out strategic planning, and it also has important reference value for bank credit departments.